Compounded GLP1 Status and Availability

Here at The Medicine Shoppe, our Injectable Compounded Semaglutide is produced by an FDA registered out-sourcing facility. These are FDA regulated pharmacies that do not sell individual rxs to patients, but they sell to other providers to be dispensed. These are of a higher quality than normal pharmacy compounded prescriptions due to the FDA regulation of cGMP practices.

The FDA on February 21st 2025, declared Semaglutide Injectable Brands to be no longer in a “shortage” status. When that happens a 503B compounding pharmacy has 60 days to wind down their productions and a 503A compounding pharmacy (Our Medicine Shoppe is this) can then sell out the remaining stock as prescriptions after the 60 days.

Pursuant to the FDA’s removal of Semaglutide Injectable Brands from the FDA Drig Shortage List, we ceased purchasing and dispensing this product.

We will continue on with producing Compounded Oral Semaglutide in the special SubMagna® base which enhances it’s absorption abilities. Call us to discuss how this product could help if you were a patient of the injectable product before.

Please check back here for updated status from time to time.